Exclusive: U.S. Cardinal Health puts $1.5 billion China business on block - sources

HONG KONG (Reuters) - U.S. drug distributor Cardinal Health has put its China business up for sale, drawing keen interest from state-backed Chinese pharmaceutical firms in a deal that may be worth up to $1.5 billion, sources familiar with the matter said.

Exclusive: U.S. Cardinal Health puts $1.5 billion China business on block - sources
Read More


Bagikan Berita Ini